MONTELUKAST

SynDRA canonical compound SYN0001854 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ALOX5 \| CYP2C8 \| CYSLTR1
Mechanism of action	leukotriene receptor antagonist
Indication	allergic rhinitis \| asthma \| exercise-induced bronchoconstriction (EIB)
Disease area	allergy \| pulmonary

All known targets

montelukast sodium
singulair
Brondilat
Singulair
Montair
Singular
Apxi toxin
MK-0476
Brondilat (TN)
Montelukast (INN)
Montelukast [INN:BAN]
Singulair (TN)
Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
MHM278SD3E
CHEBI:50730
Montelukastum
RefChem:6040
DTXCID403334
R03DC03
MK 0476
MFCD05662278
cis-Montelukast
C35H36ClNO3S
MONTELUKAST [INN]
Aerokast
Montelukast racemate
MK0476 (free acid)
SR-01000763441
UNII-MHM278SD3E
HSDB 7582
?-Hydroxy montelukast
Montelukast Impurity I
Montelukast (Standard)
MONTELUKAST [MI]